Hormones
Clinical findings and hormone testing.
The Tide / Connected careMeasure.
Measure.
Monitor.
Consider together.
Hormones, metabolic health, sleep and body composition inform the same clinical picture. That connection makes coordinated evaluation valuable—not every medication necessary.
Connected, not bundledOne clinical picture.
01 02 03 04
One clinical picture.
Individual decisions.
Metabolic health
Weight, glucose and cardiovascular context.
Sleep & recovery
Sleep history and related care needs.
Body composition
Relevant measurements beyond scale weight.
The common ground
Clinician-led evaluation
Care may follow one pathway, several separately indicated therapies, or no medication. Connections inform the assessment—not an automatic combination of treatments.
Care that continues01 02 03
A process with checkpoints.
Assessment
Medical history, current medications and appropriate testing define the clinical question.
A considered plan
The clinician reviews findings, evidence, risks, benefits, alternatives and cost. Treatment follows its own indication.
Ongoing review
Relevant monitoring, tolerability and reassessment guide the next decision.
The markers. The meaning.
Labs, translated.
A clearer view of the markers that may inform evaluation and follow-up.
AUA diagnostic-support cutoff<300 ng/dL
Total testosterone below this level can support evaluation. It is not a standalone diagnosis or an optimal target. Compatible findings and repeat testing matter.
Clinical marker guideEDUCATION / NO PATIENT VALUES
Total T
Total testosteroneTotal circulating testosterone, including bound and unbound hormone.
Why it matters
Supports evaluation alongside symptoms and repeat morning measurements; one low result is not a diagnosis.
Free T
Free testosteroneUnbound testosterone, measured or calculated with validated methods.
Why it matters
May clarify borderline total testosterone or altered SHBG; not required in every evaluation.
SHBG
Sex hormone-binding globulinProtein that binds testosterone and affects interpretation of total testosterone.
Why it matters
Helps interpret total and calculated free testosterone when binding levels differ.
LH / FSH
Luteinizing hormone / follicle-stimulating hormonePituitary signals involved in testosterone production and sperm development.
Why it matters
When indicated, helps distinguish testicular causes from pituitary or hypothalamic causes.
HbA1c
Hemoglobin A1cAverage blood glucose over approximately two to three months.
Why it matters
Helps assess diabetes risk and monitor glucose management; some blood conditions affect accuracy.
LDL / HDL / TG
Lipid panelCholesterol fractions and triglycerides in blood.
Why it matters
Adds cardiovascular risk context; goals depend on overall risk and clinical history.
DXA
Dual-energy X-ray absorptiometry · body compositionEstimates fat and lean mass; not a blood test.
Why it matters
Shows weight composition beyond the scale; measurement conditions affect comparisons.
IGF-1
Insulin-like growth factor 1 · when indicatedA blood marker reflecting growth-hormone activity, interpreted against age-based ranges.
Why it matters
For suspected growth-hormone disorders or treatment monitoring, not routine wellness screening; a result alone does not diagnose deficiency.
CBC / Hct
Complete blood count / hematocritBlood cell counts and the red-cell proportion of blood.
Why it matters
Testosterone can raise hematocrit; baseline and follow-up testing help assess treatment safety.
PSA
Prostate-specific antigenA prostate-related blood marker; not a cancer diagnosis.
Why it matters
Prostate monitoring depends on age, risk, and shared decision-making; elevated results need clinical interpretation.
Review
Clinical review · not a laboratory testSymptoms, adverse effects, treatment response, and relevant health history.
Why it matters
Connects results with examination, medications, fertility plans, and safety; numbers alone do not determine treatment.
Examples, not a fixed panel. Test selection and timing depend on indication, age, risk, medications, and treatment. Reference ranges vary by assay. DXA and clinical review are not blood tests. AUA guidance ↗
Before a conversation
A few clear answers.
Clinical context matters. These answers explain the process, not an individual recommendation.
Does connected care mean combined medications?
No. The shared assessment can lead to one pathway, several separately indicated therapies, referral or no medication. A universal TRT, GLP-1 and GH regimen is not assumed.
Can weight management affect testosterone findings?
Weight management can improve obesity-related reductions in testosterone in some men. It is not a guaranteed effect or proof that a specific medication directly stimulates testosterone production.
Is growth-hormone support a sleep treatment?
GH-axis evaluation is a separate endocrine conversation. No general sleep, testosterone or physique benefit is promised. Confirmed adult GH deficiency is a specialist pathway.
Let’s talk
Start with a conversation.
Houston clinic. Texas telehealth.